XML 169 R124.htm IDEA: XBRL DOCUMENT
v3.23.1

SHARE CAPITAL (Details Narrative) ¥ / shares in Units, $ / shares in Units, Integer in Thousands |  |  |  |  |  |  |  |  |  |  |  |  |  | 12 Months Ended |  |  |  |
--- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | ---
Oct. 04, 2022 | Sep. 30, 2022 USD ($) $ / shares shares | Sep. 30, 2022 CNY (¥) Investors | Sep. 30, 2022 USD ($) $ / shares shares | Jun. 14, 2021 USD ($) $ / shares | Jun. 10, 2021 $ / shares shares | Jun. 10, 2021 CNY (¥) Investors | Feb. 17, 2021 USD ($) $ / shares | Feb. 12, 2021 USD ($) $ / shares shares | Dec. 07, 2020 USD ($) Investors $ / shares shares | Sep. 03, 2020 $ / shares shares | Sep. 03, 2020 $ / shares shares | May 27, 2020 USD ($) $ / shares | May 22, 2020 USD ($) $ / shares shares | May 22, 2020 CNY (¥) | Jan. 08, 2020 USD ($) Investors $ / shares shares | Jan. 08, 2020 CNY (¥) Investors | Dec. 18, 2019 USD ($) $ / shares | Dec. 16, 2019 USD ($) $ / shares shares | Dec. 31, 2022 CNY (¥) Integer | Dec. 31, 2021 CNY (¥) Integer shares | Dec. 31, 2020 CNY (¥) shares | Dec. 31, 2022 $ / shares shares | Dec. 30, 2022 $ / shares shares | Sep. 03, 2020 ¥ / shares shares | Sep. 02, 2020 shares
IfrsStatementLineItems [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Equity reverse stock split |  |  |  |  |  |  |  |  |  |  | Company effected a reverse stock split, every three issued and outstanding ordinary shares as of the effective date will automatically be combined into one issued and outstanding share | Company effected a reverse stock split, every three issued and outstanding ordinary shares as of the effective date will automatically be combined into one issued and outstanding share |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of shares outstanding |  |  |  |  |  |  |  |  |  |  | 3,100,000 | 3,100,000 |  |  |  |  |  |  |  |  | 5,976,098,000 | 3,674,370,000 | 8,057,847,000 |  | 3,100,000 | 9,200,000
Par value per share | $ / shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 0.024 | $ 0.024 |  |
Number of shares issue |  |  |  |  |  |  |  |  |  |  |  |  |  | 1,102,950 |  | 666,666 |  |  | 1,200,000 |  |  |  |  |  |  |
Share issued price per share | $ / shares |  |  |  |  |  |  |  |  |  | $ 2.32 |  |  |  | $ 0.68 |  | $ 0.75 |  |  | $ 0.75 |  |  |  |  |  |  |
Warrants to purchase shares of common stock |  |  |  |  |  |  |  |  |  |  |  |  |  | 1,102,950 |  |  |  |  | 1,200,000 |  |  |  |  |  |  |
Gross Proceeds from pricing of public offering | $ |  |  |  |  |  |  |  |  | $ 2,100,000 | $ 1,300,000 |  |  |  | $ 750,006 |  |  |  |  | $ 900,000 |  |  |  |  |  |  |
Warrant life |  |  |  |  |  |  |  | 5 years | 5 years |  |  |  | 5 years | 5 years | 5 years |  |  | 5 years | 5 years |  |  |  |  |  |  |
Warrants exercisable term |  |  |  |  |  |  |  |  | 6 months |  |  |  |  | 6 months | 6 months |  |  |  | 6 months |  |  |  |  |  |  |
Warrants exercise price per share | $ / shares |  |  |  |  |  |  |  |  | $ 4.46 |  |  |  |  | $ 0.79 |  |  |  |  | $ 0.82 |  |  |  |  |  |  |
Proceeds from offering | $ |  |  |  |  |  |  |  |  | $ 1,860,000 |  |  |  |  | $ 595,000 |  |  |  |  | $ 748,000 |  |  |  |  |  |  |
Percentage of gross proceeds of offering |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 8.00% |  |  |  |  |  |  |
Payment of placement fee | $ |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 72,000 |  |  |  |  |  |  |
Payment of non-accountable expense allowance | $ |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 45,000 |  |  |  |  |  |  |
Percentage of aggregate number of shares sold in offering |  |  |  |  |  |  |  |  | 5.00% |  |  |  |  | 5.00% | 5.00% |  |  |  | 5.00% |  |  |  |  |  |  |
Exercise price at date of grant | $ / shares |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 0.85 |  |  |  |  | $ 0.9375 |  |  |  |  |  |  |
Fair value of other than equity instrument warrant granted | ¥ |  |  |  |  |  |  |  |  |  |  |  |  |  |  | ¥ 3,552,000 |  |  |  |  | ¥ 5,250,000 |  |  |  |  |  |
Issuance of new shares for equity financing |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 500,000 |  |  |  | ¥ 5,725,000 | ¥ 29,587,000 | ¥ 16,045,000 |  |  |  |
Number of institutional accredited investors | Investors |  |  | 2 |  |  |  | 3 |  |  | 3 |  |  |  |  |  | 3 | 3 |  |  |  |  |  |  |  |  |
Registration period of offering |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 270 days | 270 days |  |  |  |  |  |  |  |  |
Legal and other expenses | ¥ |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | ¥ 0 |  |  |  |  |  |  |  |  |
Grant date | October 4, 2022 |  |  |  | June 14, 2021 |  |  | February 17, 2021 |  |  |  |  | May 27 and May 25, 2020 |  |  |  |  | December 18, 2019 |  |  |  |  |  |  |  |
Share price at date of grant |  |  |  | 0.58 | 3.15 |  |  | 4.45 |  |  |  |  |  |  |  |  |  | 0.68 |  | 1,833,334 | 1,652,322 |  |  |  |  |
Volatility |  |  |  |  |  |  |  | 107.00% |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Dividend yield |  |  |  | 0.00% | 0.00% |  |  | 0.00% |  |  |  |  | 0.00% |  |  |  |  | 0.00% |  |  |  |  |  |  |  |
Risk-free interest rate |  |  |  | 3.96% | 0.80% |  |  | 0.57% |  |  |  |  | 0.34% |  |  |  |  | 1.74% |  |  |  |  |  |  |  |
Average fair value at grant date | $ |  | $ 0.43 |  | $ 0.43 | $ 2.50 |  |  | $ 3.54 |  |  |  |  | $ 0.416 |  |  |  |  | $ 0.598 |  |  |  |  |  |  |  |
Number of shares issued |  |  |  |  |  |  |  |  |  | 566,379 |  |  |  |  |  |  |  |  |  |  | 1,502,110,000 |  | 1,666,667,000 | 200,000,000 |  |
Aggregate the number of share sale |  |  |  |  |  |  |  |  | 588,235 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Purchase price of per share | $ / shares |  |  |  |  |  |  |  |  | $ 3.57 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants exercised |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 700,516 |  |  |  |  |
Warrants exercised (in shares) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 685,339 |  |  |  |  |
Warrants exercised cashless |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 32,677 |  |  |  |  |
Shares issued upon cashless exercise of warrants |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 17,500 |  |  |  |  |
Warrants exercised | ¥ |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | ¥ 10,258,000 |  |  |  |  |
Chief Financial Officer [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
IfrsStatementLineItems [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Aggregate of warrants |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 33,269 | 46,256 | 110,343 |  |  |
Fair value of shares issued | ¥ |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 621,000 | ¥ 573,000 | ¥ 587,000 |  |  |  |
Chief Executive Officer [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
IfrsStatementLineItems [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Aggregate of warrants |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 81,010 | 36,201 | 268,331 |  |  |
Fair value of shares issued | ¥ |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 1,490,000 | ¥ 1,262,000 | ¥ 548,000 |  |  |  |
Employee [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
IfrsStatementLineItems [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Aggregate of warrants |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 36,408 |  |  |
Fair value of shares issued | ¥ |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | ¥ 69,000 |  |  |  |  |  |
Investor Warrants [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
IfrsStatementLineItems [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants to purchase shares of common stock |  | 1,666,667 |  | 1,666,667 |  | 913,875 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrant life |  |  |  |  |  |  | 5 years |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants exercise price per share | $ / shares |  | $ 0.82 |  | $ 0.82 |  | $ 3.42 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Proceeds from offering | ¥ |  |  | ¥ 1,000,000 |  |  |  | ¥ 3,180,285 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Placement Agent Warrants [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
IfrsStatementLineItems [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants exercise price per share | $ / shares |  | $ 0.75 |  | $ 0.75 |  | $ 4.35 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Percentage of aggregate number of shares sold in offering |  |  | 5.00% |  |  |  | 5.00% |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Securities Purchase Agreement [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
IfrsStatementLineItems [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of shares issued |  | 1,666,667 |  | 1,666,667 |  | 913,875 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Purchase price of per share | $ / shares |  | $ 0.60 |  |  |  | $ 3.48 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Securities Purchase Agreement [Member] | Investor Warrants [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
IfrsStatementLineItems [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Closing price for the common shares preceding execution of the SPA | $ / shares |  |  |  |  |  | $ 3.42 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Bottom of range [member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
IfrsStatementLineItems [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Par value per share | (per share) |  |  |  |  |  |  |  |  |  |  | $ 0.008 | $ 0.008 |  |  |  |  |  |  |  |  |  |  |  |  | ¥ 0.008 |
Exercise price at date of grant | $ / shares |  |  |  | $ 0.82 | $ 3.42 |  |  | $ 3.57 |  |  |  |  | $ 0.79 |  |  |  |  | $ 0.82 |  |  |  |  |  |  |  |
Share price at date of grant | $ / shares |  |  |  |  |  |  |  |  |  |  |  |  | 0.59 |  |  |  |  |  |  |  |  |  |  |  |  |
Volatility |  |  |  |  |  |  |  |  |  |  |  |  | 100.00% |  |  |  |  | 141.00% |  |  |  |  |  |  |  |
Top of range [member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
IfrsStatementLineItems [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Par value per share | (per share) |  |  |  |  |  |  |  |  |  |  | $ 0.024 | $ 0.024 |  |  |  |  |  |  |  |  |  |  |  |  | ¥ 0.024 |
Warrant life |  |  |  | 5 years | 5 years |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise price at date of grant | $ / shares |  |  |  | $ 0.75 | $ 4.35 |  |  | $ 4.46 |  |  |  |  | $ 0.85 |  |  |  |  | $ 0.9375 |  |  |  |  |  |  |  |
Share price at date of grant | $ / shares |  |  |  |  |  |  |  |  |  |  |  |  | 0.64 |  |  |  |  |  |  |  |  |  |  |  |  |
Volatility |  |  |  | 104.00% | 115.00% |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |

X
- Definition Aggregate of warrants. + References No definition available. + Details
Name: | aehl_AggregateOfWarrants
Namespace Prefix: | aehl_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Aggregate the number of share sale. + References No definition available. + Details
Name: | aehl_AggregateTheNumberOfShareSale
Namespace Prefix: | aehl_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Closing price for common shares preceding execution of spa. + References No definition available. + Details
Name: | aehl_ClosingPriceForCommonSharesPrecedingExecutionOfSpa
Namespace Prefix: | aehl_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Definition Description of risk free interest rate warrant granted. + References No definition available. + Details
Name: | aehl_DescriptionOfRiskFreeInterestRateWarrantGranted
Namespace Prefix: | aehl_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Description of the reverse stock split arrangement. + References No definition available. + Details
Name: | aehl_EquityReverseStockSplit
Namespace Prefix: | aehl_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Expected dividend yield percentage warrant granted. + References No definition available. + Details
Name: | aehl_ExpectedDividendYieldPercentageWarrantGranted
Namespace Prefix: | aehl_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition The element represents the fair value of shares. + References No definition available. + Details
Name: | aehl_FairValueOfSharesIssued
Namespace Prefix: | aehl_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Fair value of other than equity instrument warrant granted. + References No definition available. + Details
Name: | aehl_FairvalueOfOtherthanEquityinstrumentWarrantGranted
Namespace Prefix: | aehl_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Gross proceeds from pricing of public offering. + References No definition available. + Details
Name: | aehl_GrossProceedsFromPricingOfPublicOffering
Namespace Prefix: | aehl_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- References No definition available. + Details
Name: | aehl_IfrsStatementLineItems
Namespace Prefix: | aehl_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Legal and other expenses. + References No definition available. + Details
Name: | aehl_LegalAndOtherExpenses
Namespace Prefix: | aehl_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Number of institutional accredited investors. + References No definition available. + Details
Name: | aehl_NumberOfInstitutionalAccreditedInvestors
Namespace Prefix: | aehl_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of shares issue. + References No definition available. + Details
Name: | aehl_NumberOfSharesIssue
Namespace Prefix: | aehl_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Represents the number of warrants exercised. + References No definition available. + Details
Name: | aehl_NumberOfWarrantsExercised
Namespace Prefix: | aehl_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Represents the number of warrants exercised cashless. + References No definition available. + Details
Name: | aehl_NumberOfWarrantsExercisedCashless
Namespace Prefix: | aehl_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Payment of non-accountable expense allowance. + References No definition available. + Details
Name: | aehl_PaymentOfNonaccountableExpenseAllowance
Namespace Prefix: | aehl_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Payment of placement fee. + References No definition available. + Details
Name: | aehl_PaymentOfPlacementFee
Namespace Prefix: | aehl_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Percentage of aggregate number of shares sold in offering. + References No definition available. + Details
Name: | aehl_PercentageOfAggregateNumberOfSharesSoldInOffering
Namespace Prefix: | aehl_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Percentage of gross proceeds of offering. + References No definition available. + Details
Name: | aehl_PercentageOfGrossProceedsOfOffering
Namespace Prefix: | aehl_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Proceeds from offering. + References No definition available. + Details
Name: | aehl_ProceedsFromOffering
Namespace Prefix: | aehl_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Purchase price of per share. + References No definition available. + Details
Name: | aehl_PurchasePriceOfPerShare
Namespace Prefix: | aehl_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Definition Registration period of offering. + References No definition available. + Details
Name: | aehl_RegistrationPeriodOfOffering
Namespace Prefix: | aehl_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Share issued price per share. + References No definition available. + Details
Name: | aehl_ShareIssuedPricePerShare
Namespace Prefix: | aehl_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Represents the number of shares issued upon cashless exercise of warrants. + References No definition available. + Details
Name: | aehl_SharesIssuedByCashlessExerciseOfWarrants
Namespace Prefix: | aehl_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Shares issued by exercise of warrants. + References No definition available. + Details
Name: | aehl_SharesIssuedByExerciseOfWarrants
Namespace Prefix: | aehl_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Warrant life. + References No definition available. + Details
Name: | aehl_WarrantLife
Namespace Prefix: | aehl_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Warrant number of securities called by warrants or rights. + References No definition available. + Details
Name: | aehl_WarrantNumberOfSecuritiesCalledByWarrantsOrRights
Namespace Prefix: | aehl_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Warrants exercisable term. + References No definition available. + Details
Name: | aehl_WarrantsExercisableTerm
Namespace Prefix: | aehl_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Warrants exercise price per share. + References No definition available. + Details
Name: | aehl_WarrantsExercisePricePerShare
Namespace Prefix: | aehl_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition The date on which share-based payment arrangements are granted. [Refer: Share-based payment arrangements [member]] + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Name IFRS -Number 2 -IssueDate 2022-03-24 -Paragraph IG23 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2022-en-r&anchor=para_IG23&doctype=Implementation%20Guidance -URIDate 2022-03-24 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Name IFRS -Number 2 -IssueDate 2022-03-24 -Paragraph 45 -Subparagraph a -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2022-en-r&anchor=para_45_a&doctype=Standard -URIDate 2022-03-24 + Details
Name: | ifrs-full_DateOfGrantOfSharebasedPaymentArrangement
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The expected volatility of the share price used to calculate the fair value of the share options granted. Expected volatility is a measure of the amount by which a price is expected to fluctuate during a period. The measure of volatility used in option pricing models is the annualised standard deviation of the continuously compounded rates of return on the share over a period of time. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2022-03-24 -Paragraph 47 -Subparagraph a -Clause i -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2022-en-r&anchor=para_47_a_i&doctype=Standard -URIDate 2022-03-24 + Details
Name: | ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted
Namespace Prefix: | ifrs-full_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition The exercise price of share options granted. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2022-03-24 -Paragraph 47 -Subparagraph a -Clause i -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2022-en-r&anchor=para_47_a_i&doctype=Standard -URIDate 2022-03-24 + Details
Name: | ifrs-full_ExercisePriceShareOptionsGranted2019
Namespace Prefix: | ifrs-full_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Definition The increase in equity through the issue of equity instruments. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 1 -IssueDate 2022-03-24 -Paragraph 106 -Subparagraph d -Clause iii -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_106_d_iii&doctype=Standard -URIDate 2022-03-24 + Details
Name: | ifrs-full_IssueOfEquity
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The number of other equity instruments (ie other than share options) granted in a share-based payment arrangement. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2022-03-24 -Paragraph 47 -Subparagraph b -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2022-en-r&anchor=para_47_b&doctype=Standard -URIDate 2022-03-24 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Name IFRS -Number 2 -IssueDate 2022-03-24 -Paragraph 45 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2022-en-r&anchor=para_45&doctype=Standard -URIDate 2022-03-24 + Details
Name: | ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:decimalItemType
Balance Type: | na
Period Type: | duration

X
- Definition The number of shares issued by the entity. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IAS -Number 1 -IssueDate 2022-03-24 -Paragraph 106 -Subparagraph d -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_106_d&doctype=Standard -URIDate 2022-03-24 + Details
Name: | ifrs-full_NumberOfSharesIssued
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition The number of shares that have been authorised and issued, reduced by treasury shares held. [Refer: Treasury shares] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 1 -IssueDate 2022-03-24 -Paragraph 79 -Subparagraph a -Clause iv -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_79_a_iv&doctype=Standard -URIDate 2022-03-24 + Details
Name: | ifrs-full_NumberOfSharesOutstanding
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition The nominal value per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 1 -IssueDate 2022-03-24 -Paragraph 79 -Subparagraph a -Clause iii -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_79_a_iii&doctype=Standard -URIDate 2022-03-24 + Details
Name: | ifrs-full_ParValuePerShare
Namespace Prefix: | ifrs-full_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition The cash inflow from the exercise of share purchase warrants. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IAS -Number 7 -IssueDate 2022-03-24 -Paragraph 17 -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_17&doctype=Standard -URIDate 2022-03-24 + Details
Name: | ifrs-full_ProceedsFromExerciseOfWarrants
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The weighted average fair value at the measurement date of granted equity instruments other than share options. [Refer: Weighted average [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2022-03-24 -Paragraph 47 -Subparagraph b -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2022-en-r&anchor=para_47_b&doctype=Standard -URIDate 2022-03-24 + Details
Name: | ifrs-full_WeightedAverageFairValueAtMeasurementDateOtherEquityInstrumentsGranted
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Details
Name: | srt_TitleOfIndividualAxis=srt_ChiefFinancialOfficerMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_TitleOfIndividualAxis=aehl_EmployeeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ComponentsOfEquityAxis=aehl_InvestorWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ComponentsOfEquityAxis=aehl_PlacementAgentWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | aehl_CollaborativeArrangementAndArrangementOtherThanCollaborativeAxis=aehl_SecuritiesPurchaseAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |